Cardlytics Inc (NASDAQ:CDLX) has a beta value of 1.55 and has seen 1.08 million shares traded in the last trading session. The company, currently valued at $200.24M, closed the last trade at $3.94 per share which meant it lost -$0.08 on the day or -1.99% during that session. The CDLX stock price is -420.81% off its 52-week high price of $20.52 and 26.65% above the 52-week low of $2.89. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.7 million shares traded. The 3-month trading volume is 796.29K shares.

The consensus among analysts is that Cardlytics Inc (CDLX) is Buy stock at the moment, with a recommendation rating of 3.17. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.

Cardlytics Inc (NASDAQ:CDLX) trade information

Sporting -1.99% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CDLX stock price touched $3.94 or saw a rise of 5.74%. Year-to-date, Cardlytics Inc shares have moved -57.22%, while the 5-day performance has seen it change 12.25%. Over the past 30 days, the shares of Cardlytics Inc (NASDAQ:CDLX) have changed -2.48%. Short interest in the company has seen 7.19 million shares shorted with days to cover at 7.82.

Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 1.5% from current levels. The projected low price target is $3.5 while the price target rests at a high of $17.0. In that case, then, we find that the current price level is -331.47% off the targeted high while a plunge would see the stock lose 11.17% from current levels.

Cardlytics Inc (CDLX) estimates and forecasts

Figures show that Cardlytics Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -58.48% over the past 6 months, with this year growth rate of -109.68%, compared to 18.40% for the industry.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -5.75% over the past 5 years. Earnings growth for 2024 is a modest -10.30% while over the next 5 years, the company’s earnings are expected to increase by 44.10%.

CDLX Dividends

Cardlytics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Cardlytics Inc (NASDAQ:CDLX)’s Major holders

Insiders own 5.14% of the company shares, while shares held by institutions stand at 61.62% with a share float percentage of 64.96%. Investors are also buoyed by the number of investors in a company, with Cardlytics Inc having a total of 159.0 institutions that hold shares in the company. The top two institutional holders are CAS INVESTMENT PARTNERS, LLC with over 6.46 million shares worth more than $53.08 million. As of 2024-06-30, CAS INVESTMENT PARTNERS, LLC held 14.9483% of shares outstanding.

The other major institutional holder is BLACKROCK INC., with the holding of over 3.15 million shares as of 2024-06-30. The firm’s total holdings are worth over $25.88 million and represent 7.2876% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . As of Jun 30, 2024 , the former fund manager holds about 2.23% shares in the company for having 1.13 shares of worth $4.47 million while later fund manager owns 1.06 shares of worth $4.16 million as of Sep 30, 2024 , which makes it owner of about 2.08% of company’s outstanding stock.